← All companies

SION

Sionna Therapeutics, Inc.

SION Nasdaq Pharmaceutical Preparations EDGAR ↗

$49.26

+2.48 +5.30%

Key statistics

from XBRL data in SEC filings

Market cap

$2.22B

Revenue (TTM)

—

Net income (TTM)

-$85.6M

EPS (TTM)

$-1.86

P/E ratio

—

Dividend yield

—

Free cash flow

-$66.7M

Cash

$63.3M

Total assets

$305M

Gross margin

—

52-week range

$16.48 – $51.57

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 18, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) May 12, 2026 10-K Fiscal year ended 2025-12-31 Mar 2, 2026 8-K Results of operations (earnings release) Mar 2, 2026 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Results of operations (earnings release) Aug 11, 2025 8-K Shareholder vote results Jun 13, 2025 8-K Regulation FD disclosure Jun 4, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 10-K Fiscal year ended 2024-12-31 Mar 20, 2025 8-K Results of operations (earnings release) Mar 20, 2025 8-K Amended charter or bylaws Feb 10, 2025

Other filings

4 Jul 9, 2026 4 Jul 9, 2026 4 PRIMARY DOCUMENT Jul 7, 2026 144 Jul 6, 2026 4 Jul 2, 2026 4 Jul 2, 2026 4 PRIMARY DOCUMENT Jun 18, 2026 4 PRIMARY DOCUMENT Jun 18, 2026 4 PRIMARY DOCUMENT Jun 18, 2026 4 Jun 18, 2026 4 PRIMARY DOCUMENT Jun 18, 2026 4 PRIMARY DOCUMENT Jun 18, 2026 4 PRIMARY DOCUMENT Jun 18, 2026 4 PRIMARY DOCUMENT Jun 18, 2026 4 PRIMARY DOCUMENT Jun 18, 2026 144/A Jun 1, 2026 4 May 29, 2026 4 May 29, 2026 144 May 29, 2026 SCHEDULE 13G/A May 15, 2026 SCHEDULE 13G/A May 12, 2026 4 May 11, 2026 4 May 11, 2026 ARS Apr 27, 2026